Key clinical point: Half of inflammatory arthritis patients receiving care in the Veterans Health Administration did not receive disease-modifying therapy within the first 90 days after diagnosis.

Major finding: Overall, 58.2% of inflammatory arthritis patients received a DMARD within the first year of diagnosis.

Study details: Retrospective review of 12,118 incident cases of inflammatory arthritis in the Veterans Health Administration during the period from 2007 through 2015.

Disclosures: The authors reported no conflicts of interest and no outside sources of funding.